{"id":"https://openalex.org/W4377234094","doi":"https://doi.org/10.1016/s2352-3018(23)00115-7","title":"Dolutegravir once daily with rifampicin for HIV and tuberculosis","display_name":"Dolutegravir once daily with rifampicin for HIV and tuberculosis","publication_year":2023,"publication_date":"2023-05-22","ids":{"openalex":"https://openalex.org/W4377234094","doi":"https://doi.org/10.1016/s2352-3018(23)00115-7","pmid":"https://pubmed.ncbi.nlm.nih.gov/37230100","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10594392"},"language":"en","primary_location":{"id":"doi:10.1016/s2352-3018(23)00115-7","doi":"https://doi.org/10.1016/s2352-3018(23)00115-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2352-3018(23)00115-7","pdf_url":null,"source":{"id":"https://openalex.org/S2531945440","display_name":"The Lancet HIV","issn_l":"2352-3018","issn":["2352-3018","2405-4704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet HIV","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10594392/pdf/nihms-1937470.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045674018","display_name":"Anushka Naidoo","orcid":"https://orcid.org/0000-0001-9550-9501","observed_orcids":["https://orcid.org/0000-0001-9550-9501"]},"institutions":[{"id":"https://openalex.org/I2800715850","display_name":"Centre for the AIDS Programme of Research in South Africa","ror":"https://ror.org/04qkg4668","country_code":"ZA","type":"other","lineage":["https://openalex.org/I2800715850"]},{"id":"https://openalex.org/I95023434","display_name":"University of KwaZulu-Natal","ror":"https://ror.org/04qzfn040","country_code":"ZA","type":"education","lineage":["https://openalex.org/I95023434"]}],"countries":["ZA"],"is_corresponding":true,"raw_author_name":"Anushka Naidoo","raw_affiliation_strings":["Center for the AIDS Program of Research in South Africa, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban 4001, South Africa. Electronic address: anushka.naidoo@caprisa.org","Center for the AIDS Program of Research in South Africa, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban 4001, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for the AIDS Program of Research in South Africa, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban 4001, South Africa. Electronic address: anushka.naidoo@caprisa.org","institution_ids":["https://openalex.org/I2800715850","https://openalex.org/I95023434"]},{"raw_affiliation_string":"Center for the AIDS Program of Research in South Africa, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban 4001, South Africa","institution_ids":["https://openalex.org/I2800715850","https://openalex.org/I95023434"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007514947","display_name":"Kelly E. Dooley","orcid":"https://orcid.org/0000-0001-9013-5256","observed_orcids":["https://orcid.org/0000-0001-9013-5256"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly E Dooley","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5045674018"],"corresponding_institution_ids":["https://openalex.org/I2800715850","https://openalex.org/I95023434"],"apc_list":{"value":6300,"currency":"USD","value_usd":6300},"apc_paid":null,"fwci":0.8231,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.69398748,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"10","issue":"7","first_page":"e422","last_page":"e423"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dolutegravir","display_name":"dolutegravir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.8169999718666077},{"id":"https://openalex.org/keywords/tuberculosis","display_name":"tuberculosis","score":0.9139999747276306},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.8090000152587891},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.7960000038146973},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8920000195503235},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5920000076293945},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.44999998807907104},{"id":"https://openalex.org/keywords/drug-stockouts","display_name":"drug stock-outs","score":0.7889999747276306},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.9679687023162842},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7884510159492493},{"id":"https://openalex.org/C83867959","wikidata":"https://www.wikidata.org/wiki/Q371467","display_name":"Scopus","level":3,"score":0.559734046459198},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.5505290031433105},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.47264355421066284},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.4608473479747772},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4104557931423187},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.32850104570388794},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3170466125011444},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2587971091270447},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.25451189279556274},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000099226","descriptor_name":"Dolutegravir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006575","descriptor_name":"Heterocyclic Compounds, 3-Ring","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/s2352-3018(23)00115-7","doi":"https://doi.org/10.1016/s2352-3018(23)00115-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2352-3018(23)00115-7","pdf_url":null,"source":{"id":"https://openalex.org/S2531945440","display_name":"The Lancet HIV","issn_l":"2352-3018","issn":["2352-3018","2405-4704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet HIV","raw_type":"journal-article"},{"id":"pmid:37230100","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37230100","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The lancet. HIV","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10594392","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10594392","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10594392/pdf/nihms-1937470.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Lancet HIV","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:10594392","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10594392","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10594392/pdf/nihms-1937470.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Lancet HIV","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1316585220","display_name":"Dolutegravir for the treatment of HIV in patients with Tuberculosis in KwaZulu-Natal South Africa","funder_award_id":"K43TW011437","funder_id":"https://openalex.org/F4320337356","funder_display_name":"Fogarty International Center"},{"id":"https://openalex.org/G2658137819","display_name":"Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa","funder_award_id":"R01AI152142","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000909486","display_name":"Mentoring Investigators in HIV and Tuberculosis Therapeutics Research","funder_award_id":"K24AI150349","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337356","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4377234094.pdf","grobid_xml":"https://content.openalex.org/works/W4377234094.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W2043390279","https://openalex.org/W2144255757","https://openalex.org/W2921471402","https://openalex.org/W2962927125","https://openalex.org/W4377292587"],"related_works":["https://openalex.org/W3010848142","https://openalex.org/W3120497746","https://openalex.org/W3026862840","https://openalex.org/W4285736633","https://openalex.org/W2934810601","https://openalex.org/W7171797496","https://openalex.org/W7129364166","https://openalex.org/W2883549090","https://openalex.org/W4377292587","https://openalex.org/W4386704227"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-05-23T00:00:00"}